Higuchi Y, Shoin S, Matsukawa S
Department of Pharmacology, Kanazawa University School of Medicine.
Jpn J Cancer Res. 1991 Aug;82(8):942-9. doi: 10.1111/j.1349-7006.1991.tb01925.x.
Glucose oxidase (GO) catalyzes the conversion of beta-D-glucose and molecular oxygen to D-glucono-delta-lactone and H2O2. H2O2 produced by GO was effective in preventing tumor growth in mice bearing not only ascites tumor but also solid tumor. The effect of GO was enhanced by the combined administration of catalase inhibitors such as 3-aminotriazole, hydroxylamine and sodium azide or the GSH synthesis inhibitor buthionine-(S,R)-sulfoximine in vivo. The cytolytic activity of GO against T-24 cultured cells in vitro was also enhanced by addition of these inhibitors together with GO. In the peritoneal cavity of mice the antitumor effect of GO seemed to be dependent on the amount of oxygen released from oxygenated fluorocarbon-43 (FC-O2), an oxygen-supplying substance. Furthermore, the combined administration of H2O2-decomposing enzyme inhibitors and FC-O2 synergistically enhanced the antitumor effect of GO. These results suggest that GO is suitable for antitumor chemotherapy and that the use of inhibitors of H2O2-decomposing enzymes and FC-O2 potentiated the GO therapy.
葡萄糖氧化酶(GO)催化β-D-葡萄糖和分子氧转化为D-葡萄糖酸-δ-内酯和H2O2。GO产生的H2O2不仅对携带腹水瘤的小鼠,而且对携带实体瘤的小鼠都能有效抑制肿瘤生长。在体内,通过联合给予过氧化氢酶抑制剂如3-氨基三唑、羟胺和叠氮化钠或谷胱甘肽合成抑制剂丁硫氨酸-(S,R)-亚砜亚胺,GO的作用得到增强。在体外,加入这些抑制剂与GO一起也能增强GO对T-24培养细胞的细胞溶解活性。在小鼠腹腔中,GO的抗肿瘤作用似乎取决于供氧物质氟碳-43(FC-O2)释放的氧量。此外,H2O2分解酶抑制剂与FC-O2联合给药可协同增强GO的抗肿瘤作用。这些结果表明,GO适用于抗肿瘤化疗,并且使用H2O2分解酶抑制剂和FC-O2可增强GO疗法。